# Intuitive Announces Innovations to Advance Quintuple Aim
Canonical URL: https://biopharmsignal.com/news/ISRG/intuitive-announces-innovations-to-advance-quintuple-aim
Ticker: ISRG
Company: Intuitive
Source: Intuitive
Published: 2026-06-25 13:46 EST
Original Source URL: https://isrg.intuitive.com
## Summary

Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security SUNNYVALE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally

## Article Body
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security SUNNYVALE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally
## Recent Company News
- 2026-06-25 13:46 EST — [Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton](https://biopharmsignal.com/news/ISRG/intuitive-announces-new-chief-commercial-and-marketing-officer-taylor-patton) — Source: Intuitive
- 2026-06-25 13:46 EST — [Intuitive Announces Innovations to Advance Quintuple Aim](https://biopharmsignal.com/news/ISRG/intuitive-announces-innovations-to-advance-quintuple-aim) — Source: Intuitive
- 2026-06-25 13:46 EST — [Intuitive Introduces Real-Time Surgical Insights for da Vinci 5](https://biopharmsignal.com/news/ISRG/intuitive-introduces-real-time-surgical-insights-for-da-vinci-5) — Source: Intuitive
- 2026-06-25 13:46 EST — [Intuitive expands AI and advanced imaging integration in Ion Endoluminal System](https://biopharmsignal.com/news/ISRG/intuitive-expands-ai-and-advanced-imaging-integration-in-ion-endoluminal-system) — Source: Intuitive
- 2026-06-25 13:46 EST — [Intuitive Announces Third Quarter Earnings](https://biopharmsignal.com/news/ISRG/intuitive-announces-third-quarter-earnings) — Source: Intuitive
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)